Study reveals high-dose Covid treatment is less effective in India than Europe
Researchers, including those from Copenhagen University Hospital and Apollo Hospitals in India, found that a larger dose (12 mg) did not show the same benefits as the standard dose (6 mg) for COVID-19 patients in India, based on survival rates and patient well-being after 90 and 180 days.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
